KYMERA THERAPEUTICS, INC. — Balance Sheet Charts
12 snapshots of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+81.7% +$751M
$1.67B
Current Assets↑+35.2% +$176M
$677M
Cash & Equivalents↑+60.2% +$54M
$144M
Receivables
$40M
Net PPE↓-15.4% -$8M
$42M
Total Liabilities↓-2.0% -$3M
$129M
Current Liabilities↑+6.2% +$4M
$63M
Account Payables↑+25.1% +$3M
$13M
Stockholders Equity↑+95.8% +$753M
$1.54B
Retained Earnings↓-38.4% -$315M
$-1.14B
Operating Lease ROU Asset↓-10.7% -$5M
$42M
Operating Lease Liability↓-6.3% -$5M
$78M
Gross PP&E↓-2.4% -$2M
$66M
Accumulated Depreciation↑+32.8% +$6M
$24M
Contract Asset↓-100.0% -$1M
$0
Contract Liability↓-100.0% -$11M
$0
Contract Liability (Current)↓-100.0% -$11M
$0
Contract Liability (Noncurrent)
$0
Remaining Performance Obligation
$51M